ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,942Medicare Part D Prescriptions Filled, Including Refills

Rank: 149 out of 910

$551K Total Retail Price of All Prescriptions

Rank: 134 out of 910

187 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 187 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 187 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,964 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 442 404 1 1
LISINOPRIL 333 232 2 2
SIMVASTATIN 262 181 3 3
GABAPENTIN 261 173 4 13
FUROSEMIDE 256 215 5 9
LANTUS 237 178 6 30
WARFARIN SODIUM 204 177 7 11
AMLODIPINE BESYLATE 200 170 8 4
DIVALPROEX SODIUM 190 160 9 73
METOPROLOL TARTRATE 181 135 10 7
NAMENDA 157 141 11 57
RISPERIDONE 152 123 12 67
HYDROCODONE-ACETAMINOPHEN 151 102 S3 13 8
CITALOPRAM HBR 146 124 14 19
OMEPRAZOLE 142 108 15 5
NOVOLOG 121 99 16 78
DONEPEZIL HCL 114 111 17 32
IPRATROPIUM-ALBUTEROL 111 111 18 118
MIRTAZAPINE 102 88 19 68
ISOSORBIDE MONONITRATE ER 99 99 20 81
CYMBALTA 97 80 21 58
ALENDRONATE SODIUM 96 81 22 22
QUETIAPINE FUMARATE 94 84 23 70
DIVALPROEX SODIUM ER 92 69 24 123
METFORMIN HCL 91 55 25 6
ATENOLOL 86 73 26 10
LACTULOSE 82 75 27 109
OLANZAPINE 76 75 28 145
SERTRALINE HCL 76 62 28 24
NOVOLIN R 74 61 30 141
PANTOPRAZOLE SODIUM 70 39 31 27
RANITIDINE HCL 68 61 32 28
LIDODERM 66 40 33 164
BENZTROPINE MESYLATE 64 24 R 34 213
CARBIDOPA-LEVODOPA 63 63 35 91
CARBAMAZEPINE 62 51 36 214
TRAZODONE HCL 60 56 37 37
FENOFIBRATE 58 27 38 55
GLIMEPIRIDE 56 20 39 56
VALPROIC ACID 55 52 40 190
POLYETHYLENE GLYCOL 3350 54 50 41 104
HYDROCHLOROTHIAZIDE 53 16 42 12
DIGOXIN 51 39 43 64
ALBUTEROL SULFATE 50 44 44 102
TAMSULOSIN HCL 50 50 44 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.